Log In Sign Up

Does Nuclear Lamina Repair Enable Epigenetic Clock Reset in Partial Reprogramming?

Does restoration of nuclear envelope integrity and Lamin-Associated Domain (LAD) tethering during OSK-mediated partial reprogramming enable recruitment of TET1/2 to age-associated CpG sites, or is pioneer-factor-driven chromatin opening strictly required for epigenetic clock reversal? Explore mechanistic causality between 3D genome architecture repair, chromatin accessibility, and DNA methylation reset in cellular rejuvenation.

By Dimitris Kyriakou, PhD in Molecular Biology·20/05/2026·13 min read

Scientific Hypothesis Generation

Why Does Partial Reprogramming Reset Only Certain Epigenetic Clock Modules?

Epigenetic clocks are not monolithic timekeepers. They are composites of functionally distinct CpG modules, each with its own aging trajectory and disease relevance. Partial reprogramming with OSKM factors reverses some of these modules while leaving others untouched, yet the molecular logic governing this selectivity remains poorly understood.

Hypothesis 1

OSKM factor binding is gated by pre-existing chromatin accessibility at clock CpG modules

The Gap

Clock CpGs can be clustered into twelve modules with distinct reprogramming responses, but it is unknown why certain modules are highly responsive while others are inert. The Yamanaka factors are known pioneer factors capable of engaging closed chromatin, yet their binding efficiency varies enormously across genomic regions. Whether the baseline chromatin state at module-specific CpG loci predicts reprogramming responsiveness has not been systematically tested.

The Claim

The selective resetting of epigenetic clock modules during partial reprogramming is determined by the pre-existing chromatin accessibility landscape at module-constituent CpG sites. Specifically, modules enriched in CpGs located within open chromatin regions (as defined by ATAC-seq signal in the source cell type) will show the greatest methylation age reversal upon transient OSKM expression.

Oct4 and Sox2 function as pioneer factors, but their pioneering capacity is not unlimited. During the brief window of partial reprogramming (typically 2 to 13 days), these factors preferentially bind and remodel loci that are already partially accessible. CpG modules residing in constitutively compacted heterochromatin, such as those at pericentromeric regions or within polycomb-repressed domains, will resist OSKM engagement during transient expression, even if the same loci are eventually reset during full reprogramming to iPSCs.

This model predicts a quantitative relationship: the fraction of module CpGs overlapping with ATAC-seq peaks in fibroblasts should correlate with the magnitude of DNAm age reduction in that module following partial reprogramming.

Why It's Testable Now

ATAC-seq, single-cell multiomics (scNMT-seq capturing methylation, nucleosome positioning, and transcription simultaneously), and existing fibroblast reprogramming time-course datasets make it possible to overlay chromatin accessibility maps onto clock module CpG coordinates at single-cell resolution. The twelve-module classification from spectral clustering of 5,717 clock CpGs is publicly available.

The Intriguing Outcome

If confirmed, this would mean that the apparent "selectivity" of partial reprogramming is not a feature of the epigenetic clock's biology but rather a consequence of factor accessibility kinetics. The practical implication is significant: pre-treating cells with chromatin-opening agents (such as HDAC inhibitors or BET bromodomain inhibitors) before OSKM induction could expand the set of responsive modules and achieve more complete epigenetic rejuvenation.

This would also explain why different clock algorithms show discordant responses to reprogramming, since each clock samples different proportions of modules, and thus different proportions of accessible versus inaccessible CpGs.

Thesis Entry Points

  1. Perform ATAC-seq on human dermal fibroblasts before and at days 3, 7, and 13 of doxycycline-induced OSKM expression; intersect peaks with the twelve clock module CpG coordinates and quantify accessibility enrichment per module using Fisher's exact tests.
  2. Run scNMT-seq on the same reprogramming time course to co-measure methylation state and chromatin accessibility at individual clock CpGs within single cells; compute per-module correlations between accessibility gain and methylation age reduction.
  3. Pre-treat fibroblasts with the HDAC inhibitor valproic acid (1 mM, 48 hours) before initiating OSKM partial reprogramming and measure whether previously non-responsive clock modules now show DNAm age reversal by RRBS, using untreated OSKM-reprogrammed cells as controls.

Novelty Signal

Emerging: Chromatin accessibility is well studied in full reprogramming, but its specific role in determining which epigenetic clock modules respond to partial reprogramming has not been addressed.

Hypothesis 2

Reprogramming-responsive clock modules depend on TET-mediated active demethylation, not passive dilution

The Gap

DNA demethylation during reprogramming occurs through two mechanisms: active enzymatic removal by TET dioxygenases (TET1/2/3) via the 5-hydroxymethylcytosine (5hmC) intermediate, and passive dilution through replication without maintenance methylation. Which mechanism predominates at epigenetic clock CpGs, and whether the mechanism differs across clock modules, is unknown. The observation that partial reprogramming resets some modules but not others could reflect differential dependence on these two pathways.

The Claim

Clock modules that are responsive to partial reprogramming are enriched for CpGs that undergo TET-dependent active demethylation during OSKM induction. Non-responsive modules are enriched for CpGs whose age-associated methylation gains are maintained by DNMT1 during replication and can only be diluted through sustained proliferation, which does not occur sufficiently during the brief window of partial reprogramming.

OSKM factors (particularly Oct4 and Klf4) recruit TET1 and TET2 to specific genomic loci during early reprogramming. Clock module CpGs that overlap with TET recruitment sites will accumulate 5hmC and undergo rapid demethylation within the first days of OSKM expression. In contrast, modules located at CpGs that lack TET binding motifs or reside in regions where DNMT1 activity is maintained will retain their aged methylation state unless cell division forces passive dilution over many more rounds than partial reprogramming allows.

This creates a mechanistic bottleneck: the speed of active demethylation at specific loci, not the general capacity of the reprogramming machinery, determines which modules get reset.

Why It's Testable Now

Oxidative bisulfite sequencing (oxBS-seq) can distinguish 5mC from 5hmC at single-CpG resolution. TET1/2 ChIP-seq datasets from early reprogramming time courses exist in human and mouse fibroblasts. These can be intersected with the twelve clock module coordinates to test enrichment directly.

The Intriguing Outcome

If validated, this hypothesis would establish that the "epigenetic clock" is not a single biochemical process but at least two: one governed by active enzymatic regulation (and therefore amenable to pharmacological acceleration) and another governed by passive replication-dependent dilution. This distinction would have immediate therapeutic relevance.

Small-molecule TET activators or alpha-ketoglutarate supplementation could be used to boost active demethylation at resistant modules, potentially achieving broader clock resetting without extending OSKM expression duration (and its associated oncogenic risk from sustained c-Myc activity).

Thesis Entry Points

  1. Perform oxBS-seq on human fibroblasts at days 0, 3, 7, and 13 of OSKM partial reprogramming to quantify 5hmC accumulation at each of the 5,717 clock CpGs; compute per-module 5hmC enrichment scores and correlate with previously reported module-level DNAm age reversal magnitudes.
  2. Intersect published TET1 and TET2 ChIP-seq peaks from early reprogramming (days 2 to 5) with clock module CpG coordinates; test whether responsive modules show statistically significant overlap with TET binding sites using permutation-based enrichment analysis.
  3. Perform OSKM partial reprogramming in fibroblasts with and without the TET inhibitor Bobcat339 (10 microM); measure module-level DNAm age by RRBS to determine whether blocking TET activity selectively abolishes resetting in the responsive modules while leaving non-responsive modules unchanged.

Novelty Signal

Open field: While TET enzymes are known to participate in reprogramming-associated demethylation broadly, no study has mapped TET dependence onto the specific twelve-module architecture of epigenetic clocks.

Hypothesis 3

Reprogramming-resistant clock modules encode tissue-identity CpGs shielded by lineage transcription factors

The Gap

A central puzzle of partial reprogramming is that cells retain their identity while losing epigenetic age. This implies that the aging-associated methylation changes reversed by OSKM are somehow separable from the methylation patterns that define cell type. Whether this separation maps onto the modular structure of epigenetic clocks is unknown. It is also unclear whether the resistance of certain clock modules to reprogramming is a passive consequence of chromatin inaccessibility or an active process maintained by lineage-specific transcription factors.

The Claim

Clock modules that resist partial reprogramming are enriched for CpGs within or proximal to binding sites of lineage-specific transcription factors. These factors (such as AP-1 family members in fibroblasts, GATA factors in hematopoietic cells, or HNF4-alpha in hepatocytes) maintain local methylation states that encode cell identity. During partial reprogramming, these lineage factors compete with OSKM for occupancy at shared target loci, effectively shielding identity-linked CpGs from demethylation.

This "epigenetic firewall" operates through a specific mechanism: lineage transcription factors recruit DNMT3A/3B to their binding sites, actively re-methylating any CpGs that the OSKM factors transiently demethylate. The result is a tug-of-war that the lineage factors win during partial reprogramming (because OSKM expression is transient) but lose during full reprogramming (because sustained OSKM expression eventually overwhelms the maintenance signal).

This model predicts that reprogramming-resistant modules will show tissue-specific composition: the specific CpGs within a "resistant" module that are shielded will differ between fibroblasts and, for example, hepatocytes, reflecting their distinct lineage factor repertoires.

Why It's Testable Now

Cross-referencing clock module CpGs with ENCODE/Roadmap transcription factor binding site databases across multiple cell types is computationally straightforward. Single-cell reprogramming datasets (with matched methylome and transcriptome readouts) now exist for fibroblasts, and organ-specific OSKM reprogramming data from mouse models (liver, brain, muscle) enable cross-tissue comparisons.

The Intriguing Outcome

If confirmed, this hypothesis would fundamentally reframe how we understand the relationship between biological aging and cellular identity at the epigenetic level. It would mean that epigenetic clocks inadvertently capture two superimposed signals: a "pure aging" signal (in responsive modules) and an "identity-aging hybrid" signal (in resistant modules) where age-associated methylation changes occur at loci that also encode cell type.

For rejuvenation therapy design, this is critical. Interventions that target only the "pure aging" modules would carry lower risk of identity disruption. Conversely, clocks constructed exclusively from responsive-module CpGs would be more specific biomarkers for the reversible component of epigenetic aging.

Thesis Entry Points

  1. Compute enrichment of lineage-specific transcription factor binding sites (from ENCODE ChIP-seq in fibroblasts, hepatocytes, and hematopoietic cells) at CpGs belonging to each of the twelve clock modules; test whether resistant modules show significantly higher overlap with lineage factor peaks than responsive modules using logistic regression controlling for CpG density and genomic context.
  2. Perform partial OSKM reprogramming in parallel in human dermal fibroblasts and human hepatocytes (same donor); measure module-level DNAm age change by Illumina EPIC array in both cell types and test whether the identity of resistant modules differs between the two lineages as predicted by their distinct lineage factor repertoires.
  3. Use CRISPRi to knock down expression of the fibroblast lineage factor AP-1 (c-Jun/c-Fos) during OSKM partial reprogramming in fibroblasts; measure whether previously resistant clock modules now become responsive to reprogramming by targeted bisulfite sequencing at module CpG coordinates, using scrambled-guide CRISPRi controls.

Novelty Signal

Frontier: No published work directly tests whether lineage transcription factors actively maintain reprogramming resistance at specific epigenetic clock modules, or whether this resistance is tissue-specific in its module-level pattern.

Frequently asked questions

What are epigenetic clock modules?

Epigenetic clock modules are groups of CpG sites that share similar methylation dynamics during aging. Research using spectral clustering identified twelve distinct modules within 5,717 CpGs drawn from fifteen commonly used epigenetic clocks. Each module has different relationships to tissue type, disease risk, mortality prediction, and response to reprogramming interventions.

Why does partial reprogramming not reset the entire epigenetic clock?

Partial reprogramming with OSKM factors selectively affects certain CpG modules while leaving others largely unchanged. This is likely because different modules are governed by distinct regulatory mechanisms (chromatin accessibility, enzymatic demethylation pathways, lineage factor protection), and the brief window of transient OSKM expression engages only a subset of these mechanisms.

What is the difference between partial and full reprogramming?

Full reprogramming converts somatic cells into induced pluripotent stem cells over weeks of sustained OSKM expression, erasing cellular identity entirely and resetting the epigenetic clock to near-zero. Partial reprogramming uses brief, controlled expression (typically 2 to 13 days) to reduce epigenetic age by 20 to 30 years while preserving the cell's type-specific gene expression and function.

Can selective clock module resetting explain tissue-specific reprogramming outcomes?

Possibly. Different tissues have distinct proportions of clock modules contributing to their overall epigenetic age estimate. If partial reprogramming preferentially targets modules enriched in one tissue but sparse in another, this would produce the inconsistent rejuvenation responses observed across organs in whole-body reprogramming studies, where some tissues (e.g. kidney, liver) show age reversal and others do not.

What techniques can measure module-level epigenetic changes?

Reduced-representation bisulfite sequencing (RRBS) and Illumina EPIC arrays can profile CpG methylation at single-site resolution. Oxidative bisulfite sequencing (oxBS-seq) can further distinguish 5-methylcytosine from 5-hydroxymethylcytosine. Combined with spectral clustering or weighted correlation network analysis, these methods allow researchers to decompose clock signals into functionally distinct modules and track each module's response to interventions independently.

Are these hypotheses relevant to clinical rejuvenation therapies?

Directly. Understanding which clock modules are causally linked to functional aging (mortality, disease risk) versus which are bystander marks or identity signals could guide the design of targeted epigenetic therapies. Interventions could be engineered to reset only the modules associated with functional decline, reducing the risk of disrupting cellular identity or activating oncogenic pathways.

How does BioSkepsis generate these hypotheses?

BioSkepsis synthesises peer-reviewed literature with citation-grounded analysis to identify knowledge gaps and unresolved mechanistic questions. It then formulates specific, falsifiable hypotheses with concrete experimental entry points, ensuring every claim is traceable to verified published sources. The platform is designed to accelerate the transition from literature review to testable research directions.

Generate Testable Hypotheses from Peer-Reviewed Literature

BioSkepsis synthesises published research into citation-grounded hypotheses with specific experimental entry points. Start exploring knowledge gaps in epigenetic aging, reprogramming biology, and beyond.

Start free

Sources and further reading

  1. Simpson DJ, Olova NN, Chandra T. Clock Work: Deconstructing the Epigenetic Clock Signals in Aging, Disease, and Reprogramming. bioRxiv. 2022. doi:10.1101/2022.02.13.480245
  2. Puri D, Wagner W. Epigenetic rejuvenation by partial reprogramming. BioEssays. 2023;45(4):e2200208. PMID: 36781410
  3. Gill D, Parry A, Santos F, et al. Multi-omic rejuvenation of human cells by maturation phase transient reprogramming. eLife. 2022;11:e71624. PMID: 35390271
  4. Paine PT, Nguyen A, Ocampo A. Partial cellular reprogramming: A deep dive into an emerging rejuvenation technology. Aging Cell. 2024;23(2):e14039. PMID: 38044774
  5. Lu Y, Brommer B, Tian X, et al. Reprogramming to recover youthful epigenetic information and restore vision. Nature. 2020;588(7836):124-129. PMID: 33268865
  6. Browder KC, Reddy P, Rodriguez-Esteban C, et al. In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice. Nat Aging. 2022;2(3):243-253. PMID: 37118370
  7. Macip CC, Marchena AM, Arriaga-Canon C, et al. Gene therapy-mediated partial reprogramming extends lifespan and reverses age-related changes in aged mice. Cell Reprogram. 2024;26(1):24-32. PMID: 38170117
  8. Ocampo A, Reddy P, Martinez-Redondo P, et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell. 2016;167(7):1719-1733.e12. PMID: 27984723
  9. Soufi A, Donahue G, Zaret KS. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell. 2012;151(5):994-1004. PMID: 23159369
  10. Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018;19(6):371-384. PMID: 29643443